Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 78 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
771 13.8 months Metastatic renal cell carcinoma 4 Immunotherapy
The Cleveland Clinic Foundation United States 7/2004
Treatment Details: Patients: This Phase I study involved 26 patients with metastatic renal cell carcinoma or malignant melanoma; nineteen men and seven women. The median age was 59. The majority of patients
 
772 13.8 months Relapsed GBM 4 Chemotherapy
Azienda Ospedale-Universita Italy 6/2002
Treatment Details: Patients: This Phase II study involved 58 patients with glioblastoma multiforme. These patients had already relapsed or progressed after surgery and standard radiotherapy. Treatment: The
 
773 13.8 months Hepatocellular carcinoma 5 Biologic therapy
University of Barcelona Spain 6/2013
Treatment Details: Patients: This phase 2 study involved 36 hepatocellular carcinoma patients who had been previously treated with sorafenib. The median patient age was 61 years and 89% were male. Treatme
 
774 13.8 months Metastatic breast cancer 3 Chemotherapy
Medical Center Alkmaar Netherlands 3/2014
Treatment Details: Patients: This phase 3 study involved elderly (65 years or older) female metastatic breast cancer patients who were divided into two different treatment groups. Group A consisted of 40 pat
 
775 13.8 months Advanced Epithelial Ovarian Cancer 3 Biologic therapy
Chemotherapy
Zhengzhou University Affiliated Cancer Hospital China 1/2015
Treatment Details: Patients: This study involved 52 advanced epithelial ovarian cancer patients who had received previous platinum- or taxane-based chemotherapy. The median patient age was 55 years. Treat
 
776 13.7 months Platinum-Resistant Ovarian Cancer 3 Chemotherapy
Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione GPascale IRCCS Italy 4/2015
Treatment Details: Patients: This phase 2 study involved platinum-resistant or platinum-refractory ovarian cancer patients who had received prior chemotherapy. Patients were divided into two separate treatme
 
777 13.7 months Recurrent platinum-resistant ovarian cancer 4 Biologic therapy
University Hospital of Gieben and Marburg Germany 9/2012
Treatment Details: Patients: This phase 2 study involved 37 ovarian cancer patients who had recurrence of their cancer following previous platinum-based chemotherapy. The average patient age was 58.5 years.
 
778 13.7 months Adult T-cell leukemia-lymphoma 4 Biologic therapy
Nagoya City University Graduate School of Medical Sciences Japan 3/2012
Treatment Details: Patients: This study involved 27 patients with relapsed, aggressive CCR4-positive adult T-cell leukemia-lymphoma. The median age was 64 years and 44% of the patients were male. Treatmen
 
779 13.7 months Advanced hepatocellular carcinoma 5 Biologic therapy
Chemotherapy
University of Pisa Italy 10/2011
Treatment Details: Patients: This phase II study involved 39 patients with advanced hepatocellular carcinoma. The median patient age was 67 years and 85% were male. Treatment: Patients were treated with
 
780 13.7 months Advanced hepatocellular carcinoma 5 Biologic therapy
Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 11/2010
Treatment Details: Patients: This phase 3 trial involved patients with hepatocellular carcinoma who had no previous systemic cancer treatment. Patients were separated into two treatment groups. Group 1 incl
 
Page 78 of 187  | Previous Page  | Next Page